web analytics
t1
t8
t7
t3
t9

Welcome to Discuva

Discuva is a drug discovery company focused on the creation of Next Generation targeted antimicrobials against new emerging and drug-resistant bacterial pathogens.

From a study of 114 countries, the World Health Organisation has predicted a future where all current antibiotic drugs are ineffective. In this ‘post-antibiotic era’ a simple scratch or routine surgical procedure will be a potentially life-threatening event.

At Discuva, using ground-breaking new technologies, we are successfully developing completely new classes of antibiotics which we believe will play a major role in protecting society from the forthcoming threat promised by the emergence of drug-resistant bacteria.

Upcoming Events

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
RT @TheUrgentNeed: 'Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand' | Journal of Antimicrobial…
Discuva Ltd @DiscuvaLtd
Record boost to R&D and new transport fund to help build economy fit for the future https://t.co/fPonjdUeWy
Discuva Ltd @DiscuvaLtd
Rare strain of #gonorrhea identified in Canada, compounding fears of drug resistance #superbugs https://t.co/tBMVlQ4Y3P via @statnews